CA
NZ
UK
AU
IND
US
Scholar Rock Holding Corporation filed a Form 8-K on November 10, 2026, disclosing that its subsidiary Scholar Rock Inc. entered into an asset purchase agreement to sell a Rare Pediatric Disease Priority Review Voucher to BioNTech US Inc. for $205 million in cash, and …
Urban One, Inc. reported its third-quarter results for the three months ended September 30, 2026, disclosing a net loss attributable to common stockholders of approximately $119.2 million and an operating loss of approximately $126.6 million, driven largely by a goodwill and asset impairment charge …
AAON, Inc. filed an 8-K on November 10, 2026, announcing that its Board of Directors declared a regular quarterly cash dividend of $0.10 per share, payable on December 17, 2026, to stockholders of record as of the close of business on November 25, 2026.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of approximately 5% of Cummins Inc's common stock as of September 30, 2026.
Enova International announced on November 10, 2026 that its Board of Directors authorized a new $500 million share repurchase program expiring June 30, 2028, replacing an existing $400 million program that had been set to expire June 30, 2027.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in CytomX Therapeutics Inc as of September 30, 2026.
Enova International, Inc. filed a current report on November 10, 2026, disclosing that its Board of Directors authorized a new share repurchase program of up to $500 million, replacing the prior $400 million program.
State Street Corporation filed a Schedule 13G with the SEC on November 9, 2026, disclosing beneficial ownership of 5,827,886 shares of common stock in Dakota Gold Corp as of September 30, 2026.
Harvard Bioscience, Inc. filed a Form 8-K on November 10, 2026, disclosing under Item 7.01 (Regulation FD) that the company had attached its current corporate slide presentation, dated November 2026, for distribution to the investment community.
State Street Corporation filed a Schedule 13G with the SEC on November 10, 2026, disclosing a beneficial ownership position in Cullinan Therapeutics Inc. common stock as of September 30, 2026.
Please wait processing your request...